The medicine regulator of the U.S. has already said that around 30 people in the U.K. have already experienced some rare types of blood clots after receiving this AstraZeneca Oxford vaccine, but he has already warned that this was very early for knowing if this shot has itself triggered these clots.
The Risk Of The AstraZenaca’s Vaccine And Increase In Blood Clots
The MHRA or Medicines and Healthcare products Regulatory Agency said that in the statement later on Thursday which has received around 22 reports of the CVST or cerebral venous sinus thrombosis, in which the clotting forms in sinuses which had drained blood from the brain, and 8 other reports of this thrombosis around 15.8 million people which has been given around one dose of this vaccine by twenty-first of March. This MHRA breakdown of the CVST data has shown 4 people have already died, but this agency hadn’t responded to the news agency’s questions immediately for confirming if there have been fatalities.
This agency has already advised that the U.K. for continuing the administration of this vaccine in various groups and argued that the clotting incidents are quite rare and these benefits have greatly outweighed these risks, echoing that all similar assessments by EMA or European Medicines Agency and the WHO or World Health Organization.
But as more reports of blood clots from various countries are continuously dripping in, certainly in Europe, where this AstraZeneca vaccine is greatly used. Some of the countries are currently choosing for suspending this vaccine completely, while the other countries have limited the use to various age groups.
The Netherlands on this Friday has said on administering this vaccine in the people under sixty years old for a precautionary measure after the country’s authority of medicine has reported that the blood clots among various women aged from 25 to 65. The Netherlands has already distributed 4 million doses of this vaccine so far.
It was followed in the country of Germany that on Tuesday after around 31 reports of the CVST. 29 of the 31 had been women aged between 20 and 63, and 9 of the total patients died, as per the Reuters report citing the country medicines regulator.
Around 2.7 million Germans which has been vaccinated with the 1st dose of AstraZeneca, stating the CVST cases which are relatively very low. Complications have been reported in 1 out of 1 million of the AstraZeneca vaccinations, as per the country’s health ministry. This did not detail what these complications had been and how serious they are.
From March 30, 3 deaths in the people that have experienced another combination of the blood clotting, how the low platelet count and hemorrhaging 3 to 14 days after receiving another dose of the vaccine which was reported in Norway, this country’s agency of medicines said in this report. Norway has already administered at least 1 dose of AstraZeneca to greater than 134,00 people.
The agency of Norwegian Medicines ]believes that this is the most probable link with this vaccine, but that needs great research for clarifying exactly what triggered this as written by the agency.
Denmark has reported 2 cases of these blood clots and how the low blood platelet count changes after this vaccine; one of these cases was fatal.
One indicator for looking at this incidence. Blood clots, in general, are quite common which it is expected that a certain number of people would get them for these multiple reasons on the given day of the week. If someone has got a vaccine and develops a blood clot, unfortunately, this doesn’t essentially mean this shot had caused this clot.